METHYLATION OF ATYPICAL PROTEIN ASPARTYL RESIDUES
METHYLATION OF ATYPICAL PROTEIN ASPARTYL RESIDUES
批准号:
2442224
负责人:
CLARE M O'CONNOR
金额:
$25.62万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-08-30 至 1999-06-30
关键词:
3T3 cells Xenopus Xenopus oocyte aging aspartate calmodulin cell differentiation cell senescence chemical stability clone cells enzyme activity gene expression genetic transcription in situ hybridization laboratory mouse methylation methyltransferase neurons plasmids protein metabolism testis transfection
中文摘要
哺乳动物蛋白质异天冬氨酸甲基转移酶(PIMT)
修饰异常蛋白质
在老化蛋白质中自发产生的天冬氨酸残基。这个
该项目的实验验证了哺乳动物PIMT的假设
在修复或降解受损的细胞蛋白方面发挥作用
这一功能对于终末分化尤为重要
细胞和接近衰老的细胞。
原位杂交将用于鉴定PIMT的细胞模式
基因在脑和睾丸组织中的表达
有丝分裂后细胞和高水平的PIMT活性。这些实验将会
识别以PIMT升高为特征的精子分化阶段
表情。这项对脑组织的研究将识别出
PIMT水平升高的神经元。类似的研究将在以下方面进行
从衰老动物的脑组织中检测PIMT的变化
在衰老过程中,表达伴随着神经元功能的丧失。
PIMT水平将在培养细胞模型中进行实验操作
确定PIMT耗尽和过度表达的后果
细胞生理学。永久细胞系要么过度表达,要么
高水平转染法将构建PIMT缺陷型
含有该基因的表达载体
正义或反义PIMT基因序列。
实验将测量PIMT剂量对细胞蛋白质的影响
新陈代谢,承受营养压力的能力,进入
衰老和分化为神经元表型。
将使用生化模型来确定PIMT在
蛋白质修复或降解。放射性标记的钙调蛋白将是
在人工老化方案中转化为异构化形式。这些
将底物注射到非洲爪哇卵母细胞中,并观察其稳定性
蛋白质将在没有和存在甲基化的情况下进行测量
用于确定羧甲基化是减少还是增加的抑制剂
蛋白质稳定性。肽图谱将被用来监测任何修复
反应。
通过允许功能障碍的蛋白质在细胞中积累,PIMT
功能障碍可能导致不孕症和神经退行性变
与衰老相关的疾病。例如,L-异天冬氨酸残基
在贝塔淀粉样多肽的多个位置被鉴定
阿尔茨海默病的大脑,增加了缺乏
甲基化导致了异常的加工反应,因为
疾病。甲基化途径的阐明及其与细胞周期调控的关系
识别提高其效率的效应器可能会
治疗涉及缺陷的年龄相关性疾病的潜在价值
在蛋白质代谢方面。
英文摘要
The mammalian protein isoaspartyl methyltransferase (PIMT) specifically
modifies abnormal protein
aspartyl residues that have arisen spontaneously in aging proteins. The
experiments of this project test the hypothesis that mammalian PIMT
plays a role in repairing or degrading damaged cellular proteins that
this function is particularly important for terminally differentiated
cells and for cells approaching senescence.
In situ hybridization will be used to identify cellular patterns of PIMT
gene expression in brain and testis, tissues with large numbers of
postmitotic cells and high levels of PIMT activity. The experiments will
identify stages of sperm differentiation characterized by increased PIMT
expression. The studies with brain tissue will identify groups of
neurons with elevated PIMT levels. Similar studies will be done with
brain tissue from aging animals to test whether changes in PIMT
expression accompany the loss of neuronal function during aging.
PIMT levels will be experimentally manipulated in cultured cell models
to determine the consequences of PIMT depletion and overexpression on
cellular physiology. Permanent cell lines that either overexpress or are
deficient in PIMT will be constructed by transfection with high level
expression plasmids containing the
PIMT gene sequence in either sense or antisense orientations.
Experiments will measure the effects of PIMT dosage on cellular protein
metabolism, ability to survive nutritional stress, tendency to enter
senescence and differentiation to a neuronal phenotype.
A biochemical model will be used to identify roles for the PIMT in
protein repair or degradation. Radiolabeled calmodulins will be
converted to isomerized forms in an artificial aging protocol. These
substrates will be injected into Xenopus oocytes and the stability of
the protein will be measured in the absence and presence of methylation
inhibitors to determine if carboxyl methylation decreases or increases
protein stability. Peptide mapping will be used to monitor any repair
reactions.
By allowing dysfunctional proteins to accumulate in cells, PIMT
malfunction could contribute to infertility and neurodegenerative
disorders associated with aging. For example, L-isoaspartyl residues
have been identified at several locations in beta-amyloid peptides from
Alzheimer-diseased brains, raising the possibility that deficiencies in
methylation contribute to the aberrant processing reactions in that
disease. The elucidation of the methylation-mediated pathway and the
identification of effectors that increase its efficiency could have
potential value in treating age-related disorders which involve defects
in protein metabolism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FASEB Research Conference on Biological Methylation
-
批准号:6360056
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2001
-
负责人:CLARE M O'CONNOR
-
依托单位:
METHYLATION OF ATYPICAL PROTEIN ASPARTYL RESIDUES
-
批准号:2050046
-
项目类别:
-
资助金额:$19.35万
-
财政年份:1985
-
负责人:CLARE M O'CONNOR
-
依托单位:
METHYLATION OF ATYPICAL PROTEIN ASPARTYL RESIDUES
-
批准号:2732502
-
项目类别:
-
资助金额:$26.63万
-
财政年份:1985
-
负责人:CLARE M O'CONNOR
-
依托单位:
METHYLATION OF ATYPICAL PROTEIN ASPARTYL RESIDUES
-
批准号:3119542
-
项目类别:
-
资助金额:$24.81万
-
财政年份:1985
-
负责人:CLARE M O'CONNOR
-
依托单位:
METHYLATION OF ATYPICAL PROTEIN ASPARTYL RESIDUES
-
批准号:3119544
-
项目类别:
-
资助金额:$23.93万
-
财政年份:1985
-
负责人:CLARE M O'CONNOR
-
依托单位:
METHYLATION OF ATYPICAL PROTEIN ASPARTYL RESIDUES
-
批准号:3288329
-
项目类别:
-
资助金额:$17.22万
-
财政年份:1985
-
负责人:CLARE M O'CONNOR
-
依托单位:
METHYLATION OF ATYPICAL PROTEIN ASPARTYL RESIDUES
-
批准号:3288327
-
项目类别:
-
资助金额:$17.9万
-
财政年份:1985
-
负责人:CLARE M O'CONNOR
-
依托单位:
METHYLATION OF ATYPICAL PROTEIN ASPARTYL RESIDUES
-
批准号:2050047
-
项目类别:
-
资助金额:$24.66万
-
财政年份:1985
-
负责人:CLARE M O'CONNOR
-
依托单位:
METHYLATION OF ATYPICAL PROTEIN ASPARTYL RESIDUES
-
批准号:3119543
-
项目类别:
-
资助金额:$25.65万
-
财政年份:1985
-
负责人:CLARE M O'CONNOR
-
依托单位:
METHYLATION OF ATYPICAL PROTEIN ASPARTYL RESIDUES
-
批准号:2050045
-
项目类别:
-
资助金额:$4.36万
-
财政年份:1985
-
负责人:CLARE M O'CONNOR
-
依托单位:
METHYLATION OF ATYPICAL PROTEIN ASPARTYL RESIDUES
-
批准号:3288328
-
项目类别:
-
资助金额:$15.37万
-
财政年份:1985
-
负责人:CLARE M O'CONNOR
-
依托单位:
METHYLATION OF ATYPICAL PROTEIN ASPARTYL RESIDUES
-
批准号:3119541
-
项目类别:
-
资助金额:$25.18万
-
财政年份:1985
-
负责人:CLARE M O'CONNOR
-
依托单位:
METHYLATION OF ATYPICAL PROTEIN ASPARTYL RESIDUES
-
批准号:3119540
-
项目类别:
-
资助金额:$24.69万
-
财政年份:1985
-
负责人:CLARE M O'CONNOR
-
依托单位:
海外基金